Literature DB >> 18006329

Influence of thyroid dysfunction on serum concentrations of adipocytokines.

Pedro Iglesias1, Juan J Díez.   

Abstract

Thyroid hormones act on several aspects of metabolic and energy homeostasis influencing body weight, thermogenesis, and lipolysis in adipose tissue. Adipocytokines are biologically active substances produced by adipocyte with different physiological functions. These substances have multiple effects on several tissues acting on the intermediate and energy metabolism. For these reasons, attention has recently been focused on the possible relationship between adipocytokines, thyroid status, and thyroid dysfunction. Leptin, a signal of satiety to the brain and regulator of insulin and glucose metabolism, reflects the amount of fat storage and is considered as a pro-inflammatory adipocytokine. Adiponectin is inversely related to the degree of adiposity, increases insulin sensitivity, and may have antiatherogenic and anti-inflammatory properties. Resistin impairs glucose homeostasis and insulin action in mice but not in humans. Resistin might be considered a pro-inflammatory adipocytokine and participate in obesity-associated inflammation. Several reports indicate that leptin regulates thyroid function at hypothalamic-hypophyseal level and, conversely, thyroid hormones might control leptin metabolism at least in some animals studies. Both adiponectin and thyroid hormones share some physiological actions as reduction of body fat by increasing thermogenesis and lipid oxidation. Resistin also seems to be regulated by thyroid hormones, at least in rats. Thyroid dysfunction does not significantly affect serum leptin concentrations. Serum levels of adiponectin are no influenced by thyroid hypofunction; however, hyperthyroidism is associated with normal or elevated adiponectin levels. Finally, discordant results in resistin levels in thyroid dysfunction have been reported in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006329     DOI: 10.1016/j.cyto.2007.10.001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  16 in total

1.  Changes in the before and after thyroxine treatment levels of adipose tissue, leptin, and resistin in subclinical hypothyroid patients.

Authors:  Gulhan Akbaba; Dilek Berker; Serhat Isık; Mazhar Muslum Tuna; Suha Koparal; Murat Vural; Fatma Meric Yılmaz; Canan Topcuoglu; Serdar Guler
Journal:  Wien Klin Wochenschr       Date:  2015-09-22       Impact factor: 1.704

2.  The Association Between Three Adipocytokines (Adiponectin, Resistin and Visfatin) And Thyroid Status in Patients With Type 2 Diabetes Mellitus and Autoimmune Thyroiditis.

Authors:  Š Sotak; Z Schroner; I Lazúrová; M Felšőci; I Jochmanová; D Petrášová; I Bertková; M Mitníková; B Nováková; H Wagnerová; O Bobelová
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

3.  Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.

Authors:  M Ozkaya; M Sahin; E Cakal; F Yuzbasioglu; K Sezer; M Kilinc; S Simsek Imrek
Journal:  J Endocrinol Invest       Date:  2009-05-15       Impact factor: 4.256

4.  Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue.

Authors:  C R González; J E Caminos; M J Vázquez; M F Garcés; L A Cepeda; A Angel; A C González; M E García-Rendueles; S Sangiao-Alvarellos; M López; S B Bravo; R Nogueiras; C Diéguez
Journal:  J Physiol       Date:  2009-05-26       Impact factor: 5.182

5.  Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism.

Authors:  Kemal Ağbaht; Murat Faik Erdogan; Rifat Emral; Nilgun Baskal; Sevim Güllü
Journal:  Endocrine       Date:  2013-04-10       Impact factor: 3.633

6.  Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria.

Authors:  Carolina Castro Porto Silva Janovsky; Fernando H Cesena; Viviane Arevalo Tabone Valente; Raquel Dilguerian de Oliveira Conceição; Raul D Santos; Márcio Sommer Bittencourt
Journal:  Eur Thyroid J       Date:  2018-08-29

7.  Association of decreased muscle mass with reduced bone mineral density in patients with Graves' disease.

Authors:  Yongze Zhang; Yuzhen Ke; Lingning Huang; Ximei Shen; Sunjie Yan; Fengying Zhao; Yimei Li; Yuxi Lin
Journal:  Endocrine       Date:  2022-01-22       Impact factor: 3.633

8.  Body fatness and markers of thyroid function among U.S. men and women.

Authors:  Cari M Kitahara; Elizabeth A Platz; Paul W Ladenson; Alison M Mondul; Andy Menke; Amy Berrington de González
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

9.  Effects of thyroid dysfunction on lipid profile.

Authors:  C V Rizos; M S Elisaf; E N Liberopoulos
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

10.  Weight homeostasis & its modulators in hyperthyroidism before & after treatment with carbimazole.

Authors:  Pinaki Dutta; Anil Bhansali; Rama Walia; Niranjan Khandelwal; Sambit Das; Shariq Rashid Masoodi
Journal:  Indian J Med Res       Date:  2012-08       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.